Development and Validation of a New Multiparametric Random Survival Forest Predictive Model for Breast Cancer Recurrence with a Potential Benefit to Individual Outcomes-Reference-Cited by-同舟云学术

Development and Validation of a New Multiparametric Random Survival Forest Predictive Model for Breast Cancer Recurrence with a Potential Benefit to Individual Outcomes

Published:2022-03 Issue: Volume:Volume 14 Page:909-923
ISSN:1179-1322
Container-title:Cancer Management and Research
language:en
Short-container-title:CMAR

Author:

Li Huan^ORCID,Liu Ren-Bin,Long Chen-Meng,Teng Yuan,Cheng Lin,Liu Yu

Publisher

Informa UK Limited

Subject

Oncology

Reference53 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Female Breast Cancer Incidence Among Asian and Western Populations: More Similar Than Expected

3. Hereditary Breast Cancer in the Han Chinese Population

4. Prognostic and predictive biomarkers in breast cancer: Past, present and future

5. The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combining lymph node ratio to develop prognostic models for postoperative gastric neuroendocrine neoplasm patients;World Journal of Gastrointestinal Oncology;2024-08-15

2. Integration of body composition data in developing a Random Survival Forest model for the Prognosis of Locally Advanced Cervical Cancer patients treated with definitive Chemoradiotherapy;2024-04-25

3. Scutellaria barbata D.Don extract regulates Ezrin-mediated triple negative breast cancer progress via suppressing the RhoA /ROCK1 signaling;Toxicology Research;2024-03-01

4. Predictive value of machine learning for breast cancer recurrence: a systematic review and meta-analysis;Journal of Cancer Research and Clinical Oncology;2023-06-11

5. Machine Learning–Based Overall Survival Prediction of Elderly Patients With Multiple Myeloma From Multicentre Real-Life Data;Frontiers in Oncology;2022-06-30